Clinicopathologic correlations of renal microthrombosis and inflammatory markers in proliferative lupus nephritis

被引:23
作者
Gonzalo, Elena [1 ]
Toldos, Oscar [2 ]
Martinez-Vidal, Maria P. [3 ]
Ordonez, Maria C. [4 ]
Santiago, Begona [1 ]
Fernandez-Nebro, Antonio [4 ]
Loza, Estibaliz [5 ]
Garcia, Isabel [6 ]
Leon, Myriam [6 ]
Pablos, Jose L. [1 ,3 ]
Galindo, Maria [1 ,3 ]
机构
[1] Inst Invest Hosp 12 Octubre I 12, Madrid 28041, Spain
[2] Hosp 12 Octubre, Serv Anat Pathol, E-28041 Madrid, Spain
[3] Hosp 12 Octubre, Serv Reumatol, E-28041 Madrid, Spain
[4] Hosp Reg Univ Carlos Haya, Serv Reumatol, Malaga 29010, Spain
[5] Soc Espanola Reumatol, Fdn Espanola Reumatol, Unidad Invest, Madrid 28001, Spain
[6] Hosp Reg Univ Carlos Haya, Serv Anat Pathol, Malaga 29010, Spain
关键词
GLOMERULAR C4D DEPOSITION; ANTIPHOSPHOLIPID SYNDROME; HUMAN GLOMERULONEPHRITIS; COMPLEMENT ACTIVATION; VASCULAR-LESIONS; DISEASE-ACTIVITY; ERYTHEMATOSUS; ANTIBODIES; CLASSIFICATION; RECRUITMENT;
D O I
10.1186/ar3856
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Microthrombosis is often observed in lupus nephritis (LN) lesions, but its clinical significance is unknown. We evaluated the clinicopathologic correlations of renal microthrombosis and inflammatory markers in LN. Methods: Kidney biopsies from 58 patients with systemic lupus erythematosus (SLE) proliferative nephritis were analyzed with immunohistochemistry (IHC) for intravascular platelet aggregates (CD61), macrophagic infiltration (CD68), and activated complement deposition (C4d). Clinical data at the time of kidney biopsy and follow-up were analyzed with regard to pathologic IHC data. Results: Microthrombosis was present in 52% of the tissues. It was significantly more prevalent in patients with antiphospholipid antibodies (aPLs) (62% versus 42%). The presence of microthrombosis significantly correlated with higher macrophagic infiltration. Macrophagic infiltration but not microthrombosis was significantly correlated with C4d deposition. Only macrophagic infiltration showed a correlation with SLE and renal activity (proteinuria and active sediment), whereas neither the presence of CD61(+) microthrombi nor the extent of C4d deposition correlated with LN severity or outcome. Conclusions: Microthrombosis is associated with higher macrophagic infiltration in LN but does not seem to increase independently the severity of renal damage. Macrophagic infiltration was the best marker of SLE and renal activity in this LN series.
引用
收藏
页数:8
相关论文
共 33 条
[21]   Serum complement activation on heterologous platelets is associated with arterial thrombosis in patients with systemic lupus erythematosus and antiphospholipid antibodies [J].
Peerschke, E. I. B. ;
Yin, W. ;
Alpert, D. R. ;
Roubey, R. A. S. ;
Salmon, J. E. ;
Ghebrehiwet, B. .
LUPUS, 2009, 18 (06) :530-538
[22]   Update of the guidelines for lupus anticoagulant detection [J].
Pengo, V. ;
Tripodi, A. ;
Reber, G. ;
Rand, J. H. ;
Ortel, T. L. ;
Galli, M. ;
de Groot, P. G. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 (10) :1737-1740
[23]   Requirement of activation of complement C3 and C5 for antiphospholipid antibody-mediated thrombophilia [J].
Pierangeli, SS ;
Girardi, G ;
Vega-Ostertag, M ;
Liu, XW ;
Espinola, RG ;
Salmon, J .
ARTHRITIS AND RHEUMATISM, 2005, 52 (07) :2120-2124
[24]   Association between anti-β2 glycoprotein I antibodies and renal glomerular C4d deposition in lupus nephritis patients with glomerular microthrombosis: a prospective study of 155 cases [J].
Shen, Y. ;
Chen, X-W ;
Sun, C-Y ;
Dai, M. ;
Yan, Y-C ;
Yang, C-D .
LUPUS, 2010, 19 (10) :1195-1203
[25]  
TAKEMURA T, 1994, VIRCHOWS ARCH, V424, P459
[26]   SPECIAL ARTICLE - THE 1982 REVISED CRITERIA FOR THE CLASSIFICATION OF SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
TAN, EM ;
COHEN, AS ;
FRIES, JF ;
MASI, AT ;
MCSHANE, DJ ;
ROTHFIELD, NF ;
SCHALLER, JG ;
TALAL, N ;
WINCHESTER, RJ .
ARTHRITIS AND RHEUMATISM, 1982, 25 (11) :1271-1277
[27]   Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies - Prevalence, clinical associations, and long-term outcome [J].
Tektonidou, MG ;
Sotsiou, F ;
Nakopoulou, L ;
Vlachoyiannopoulos, PG ;
Moutsopoulos, HM .
ARTHRITIS AND RHEUMATISM, 2004, 50 (08) :2569-2579
[28]   Monitoring urinary levels of monocyte chemotactic and activating factor reflects disease activity of lupus nephritis [J].
Wada, T ;
Yokoyama, H ;
Su, SB ;
Mukaida, N ;
Iwano, M ;
Dohi, K ;
Takahashi, Y ;
Sasaki, T ;
Furuichi, K ;
Segawa, C ;
Hisada, Y ;
Ohta, S ;
Takasawa, K ;
Kobayashi, K ;
Matsushima, K .
KIDNEY INTERNATIONAL, 1996, 49 (03) :761-767
[29]  
Wagrowska-Danilewicz Malgorzata, 2005, Polish Journal of Pathology, V56, P115
[30]   The classification of glomerulonephritis in systemic lupus erythematosus revisited [J].
Weening, JJ ;
D'Agati, VD ;
Schwartz, MM ;
Seshan, SV ;
Alpers, CE ;
Appel, GB ;
Balow, JE ;
Bruijn, JA ;
Cook, T ;
Ferrario, F ;
Fogo, AB ;
Ginzler, EM ;
Hebert, L ;
Hill, G ;
Hill, P ;
Jennette, JC ;
Kong, NC ;
Lesavre, P ;
Lockshin, M ;
Looi, LM ;
Makino, H ;
Moura, LA ;
Nagata, M .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (02) :241-250